CORPORATES Marksans Pharma gets final USFDA approval for Loperamide Hydrochloride Tablets Nov 19, 2025
CORPORATES Marksans Pharma secures UK MHRA approval for 250 mg and 500 mg Mefenamic Acid Nov 17, 2025
Marksans Pharma’s UK Subsidiary Relonchem secures marketing authorization for Moxonidine tablets from UK MHRA Sep 23, 2025
Marksans Pharma’s UK subsidiary Relonchem secures marketing authorization from MHRA for Metformin tablets Aug 18, 2025
Marksans Pharma shares drop 13% as Q1 net profit falls 34.3% YoY to Rs 58.3 crore, revenue down 5% YoY Aug 12, 2025
Marksans Pharma subsidiary gets USFDA final approval for 20 mg Omeprazole Delayed-Release Tablets Aug 8, 2025
Marksans Pharma’s subsidiary Relonchem gets UK MHRA approval for Metformin Hydrochloride Oral Solution May 30, 2025
Marksans Pharma’s subsidiary receives one USFDA observation after cGMP inspection at New York facility Apr 28, 2025
Marksans Pharma’s Goa facility gets Australian TGA approval for Solid Dosage manufacturing Mar 20, 2025
Marksans Pharma’s subsidiary Relonchem receives marketing authorization from UK MHRA for Baclofen 10 mg tablets Mar 19, 2025